FDA OKs Genentech's Avastin for breast cancer (Reuters)
Date : 22 Feb 2008 Category : Business
Reuters - U.S. regulators approved Genentech
Inc's cancer drug, Avastin, for the treatment of breast
cancer, the company said on Friday, adding a potentially
significant new revenue source for the medicine.